Published in PLoS Pathog on March 12, 2010
Leishmaniasis: complexity at the host-pathogen interface. Nat Rev Microbiol (2011) 2.93
Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues. Immunity (2014) 2.58
Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas. Immunity (2011) 2.41
Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol (2010) 2.38
Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection. Cell Host Microbe (2013) 1.77
Apoptosis mediated leishmanicidal activity of Azadirachta indica bioactive fractions is accompanied by Th1 immunostimulatory potential and therapeutic cure in vivo. Parasit Vectors (2015) 1.41
Dendritic cells and hepatocytes use distinct pathways to process protective antigen from plasmodium in vivo. PLoS Pathog (2011) 1.27
Dynamic imaging of the effector immune response to listeria infection in vivo. PLoS Pathog (2011) 1.16
Immunobiology of visceral leishmaniasis. Front Immunol (2012) 1.10
In vivo imaging of CD8+ T cell-mediated elimination of malaria liver stages. Proc Natl Acad Sci U S A (2013) 1.10
Functional complexity of the Leishmania granuloma and the potential of in silico modeling. Front Immunol (2013) 0.95
Characterization of metabolically quiescent Leishmania parasites in murine lesions using heavy water labeling. PLoS Pathog (2015) 0.94
Regulation of immunity during visceral Leishmania infection. Parasit Vectors (2016) 0.92
Malaria and the liver: immunological hide-and-seek or subversion of immunity from within? Front Microbiol (2015) 0.88
Leishmania mitochondrial peroxiredoxin plays a crucial peroxidase-unrelated role during infection: insight into its novel chaperone activity. PLoS Pathog (2011) 0.88
A transcriptomic network identified in uninfected macrophages responding to inflammation controls intracellular pathogen survival. Cell Host Microbe (2013) 0.86
Animal models for the study of leishmaniasis immunology. Rev Inst Med Trop Sao Paulo (2014) 0.86
Invariant NKT cells drive hepatic cytokinic microenvironment favoring efficient granuloma formation and early control of Leishmania donovani infection. PLoS One (2012) 0.86
Lessons from other diseases: granulomatous inflammation in leishmaniasis. Semin Immunopathol (2015) 0.85
Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver. Infect Immun (2013) 0.85
B cell: T cell interactions occur within hepatic granulomas during experimental visceral leishmaniasis. PLoS One (2012) 0.85
Pathogen-related differences in the abundance of presented antigen are reflected in CD4+ T cell dynamic behavior and effector function in the lung. J Immunol (2014) 0.85
Regulation of hemichannels and gap junction channels by cytokines in antigen-presenting cells. Mediators Inflamm (2014) 0.83
Two-photon imaging of microbial immunity in living tissues. Microsc Microanal (2012) 0.82
Interferon regulatory factor 7 contributes to the control of Leishmania donovani in the mouse liver. Infect Immun (2010) 0.82
Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions. J Hepatol (2016) 0.81
Imaging of the host/parasite interplay in cutaneous leishmaniasis. Exp Parasitol (2010) 0.80
Advances in imaging the innate and adaptive immune response to Toxoplasma gondii. Future Microbiol (2010) 0.79
The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral Leishmaniasis. Front Immunol (2016) 0.79
IFNAR1-Signalling Obstructs ICOS-mediated Humoral Immunity during Non-lethal Blood-Stage Plasmodium Infection. PLoS Pathog (2016) 0.78
IFN-γ-Regulated Chemokines in Leishmania donovani Infection in the Liver. Infect Immun (2016) 0.77
Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection. Infect Immun (2014) 0.77
IFN-γ-induced macrophage antileishmanial mechanisms in mice: A role for immunity-related GTPases, Irgm1 and Irgm3, in Leishmania donovani infection in the liver. Exp Parasitol (2015) 0.77
Elucidation of monocyte/macrophage dynamics and function by intravital imaging. J Leukoc Biol (2015) 0.77
Recent advances in microscopic techniques for visualizing leukocytes in vivo. F1000Res (2016) 0.76
Long term intravital multiphoton microscopy imaging of immune cells in healthy and diseased liver using CXCR6.Gfp reporter mice. J Vis Exp (2015) 0.76
First human model of in vitro Candida albicans persistence within granuloma for the reliable study of host-fungi interactions. PLoS One (2012) 0.76
Disclosing the essentiality of ribose-5-phosphate isomerase B in Trypanosomatids. Sci Rep (2016) 0.75
CD4+ Recent Thymic Emigrants Are Recruited into Granulomas during Leishmania donovani Infection but Have Limited Capacity for Cytokine Production. PLoS One (2016) 0.75
Leishmanicidal Activity of Piper nigrum Bioactive Fractions is Interceded via Apoptosis In Vitro and Substantiated by Th1 Immunostimulatory Potential In Vivo. Front Microbiol (2015) 0.75
The Threshold of Protection from Liver-Stage Malaria Relies on a Fine Balance between the Number of Infected Hepatocytes and Effector CD8+ T Cells Present in the Liver. J Immunol (2017) 0.75
The kinematics of cytotoxic lymphocytes influence their ability to kill target cells. PLoS One (2014) 0.75
The Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi Infection. Biomed Res Int (2015) 0.75
Helminth-induced Ly6C(hi) monocyte-derived alternatively activated macrophages suppress experimental autoimmune encephalomyelitis. Sci Rep (2017) 0.75
Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol (2004) 36.25
Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science (2007) 9.54
The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med (1990) 6.19
Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur J Immunol (2003) 5.73
Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity (1997) 5.44
Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity (1996) 4.68
Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity (2007) 4.65
Migratory properties of naive, effector, and memory CD8(+) T cells. J Exp Med (2001) 4.17
Who puts the tubercle in tuberculosis? Nat Rev Microbiol (2006) 4.01
Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity (2006) 3.92
Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity (2008) 3.91
The liver as an immunological organ. Hepatology (2006) 3.86
Toll-like receptors and adaptor molecules in liver disease: update. Hepatology (2008) 3.72
Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity (2007) 3.61
Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med (2000) 3.26
Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol (2009) 3.17
Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity (2003) 3.14
In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor. J Exp Med (2007) 2.89
TCR-Mediated internalization of peptide-MHC complexes acquired by T cells. Science (1999) 2.70
Tyrosine kinase receptor RET is a key regulator of Peyer's patch organogenesis. Nature (2007) 2.65
Role of Kupffer cells in host defense and liver disease. Liver Int (2006) 2.55
Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice. J Clin Invest (2008) 2.52
Random migration precedes stable target cell interactions of tumor-infiltrating T cells. J Exp Med (2006) 2.43
Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood (2007) 2.37
Immunopathogenesis of human schistosomiasis. Parasite Immunol (2009) 1.94
Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis. J Immunol (1988) 1.87
Behavior of parasite-specific effector CD8+ T cells in the brain and visualization of a kinesis-associated system of reticular fibers. Immunity (2009) 1.84
Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease. J Exp Med (2001) 1.82
Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses. J Exp Med (2001) 1.79
Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis. J Immunol (2000) 1.72
Dynamics of T cell, antigen-presenting cell, and pathogen interactions during recall responses in the lymph node. Immunity (2009) 1.71
Systems biology of persistent infection: tuberculosis as a case study. Nat Rev Microbiol (2008) 1.70
Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in Leishmania amastigotes. Mol Biochem Parasitol (2000) 1.68
Tissue granuloma structure-function in experimental visceral leishmaniasis. Int J Exp Pathol (2001) 1.67
Differentiation and function of Kupffer cells. Med Electron Microsc (2004) 1.65
The immunopathology of experimental visceral leishmaniasis. Immunol Rev (2004) 1.64
Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice. J Immunol (1999) 1.61
Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. J Immunol (1987) 1.60
iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS Pathog (2009) 1.53
The dynamics of granuloma formation in experimental visceral leishmaniasis. J Exp Med (1988) 1.51
Antigen-specific primary activation of CD8+ T cells within the liver. J Immunol (2001) 1.47
Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology (2008) 1.41
Dynamic Imaging of CD8(+) T cells and dendritic cells during infection with Toxoplasma gondii. PLoS Pathog (2009) 1.37
Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani. Infect Immun (2007) 1.36
Dynamic imaging of T cell-parasite interactions in the brains of mice chronically infected with Toxoplasma gondii. J Immunol (2009) 1.35
Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis. Trends Parasitol (2004) 1.32
Purification of rat hepatic stellate cells by side scatter-activated cell sorting. Hepatology (1998) 1.31
Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity. Infect Immun (2003) 1.28
B7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infections. PLoS Pathog (2009) 1.27
Antigen presentation by macrophages harboring intravesicular pathogens. Parasitol Today (1999) 1.25
Macrophage activation in vivo and in vitro. Exp Cell Res (1977) 1.22
Pulmonary histoplasmosis. Radiology (1996) 1.22
Immunotherapy with OX40L-Fc or anti-CTLA-4 enhances local tissue responses and killing of Leishmania donovani. Eur J Immunol (2004) 1.19
Decoding the dynamics of T cell-dendritic cell interactions in vivo. Immunol Rev (2008) 1.16
Physiology and pathophysiology of liver inflammation, damage and repair. J Physiol Pharmacol (2008) 1.15
Three-colour fluorescence immunohistochemistry reveals the diversity of cells staining for macrophage markers in murine spleen and liver. J Immunol Methods (2008) 1.13
Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis. PLoS Pathog (2008) 1.11
Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-dependent manner. Eur J Immunol (1999) 1.08
Differences in Lsh gene control over systemic Leishmania major and Leishmania donovani or Leishmania mexicana mexicana infections are caused by differential targeting to infiltrating and resident liver macrophage populations. Infect Immun (1988) 1.00
Tissue distribution of human IgG Fc receptors CD16, CD32 and CD64: an immunohistochemical study. APMIS (1993) 1.00
Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen. Infect Immun (2006) 0.98
Organ-specific immunity in canine visceral leishmaniasis: analysis of symptomatic and asymptomatic dogs naturally infected with Leishmania chagasi. Am J Trop Med Hyg (2004) 0.98
Changes in distribution, morphology, and tumor necrosis factor-alpha secretion of alveolar macrophage subpopulations during the development of bleomycin-induced pulmonary fibrosis. Am J Pathol (1992) 0.93
Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses. Mol Pharm (2009) 0.89
Hepatic fibrin-ring granulomas in visceral leishmaniasis. Gastroenterology (1988) 0.88
Recombinant interleukin-1 alpha augments granuloma formation and cytokine production but not parasite clearance in mice infected with Leishmania donovani. Infect Immun (1992) 0.88
Inflammatory cells in murine visceral leishmaniasis express a dendritic cell marker. Clin Exp Immunol (1987) 0.86
Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13. Infect Immun (2007) 0.86
In vivo recognition of ovalbumin expressed by transgenic Leishmania is determined by its subcellular localization. J Immunol (2006) 0.85
Hepatic cellular immune responses in mice with "cure" and "non-cure" phenotype to Leishmania infantum infection: importance of CD8+ T cells and TGF-beta production. FEMS Immunol Med Microbiol (2004) 0.84
Hepatic fibrin-ring granulomas: a clinicopathologic study of 23 patients. Hum Pathol (1991) 0.84
Hepatic extracellular matrix in BALB/c mice infected with Leishmania donovani. Int J Exp Pathol (1996) 0.82
The pathogen receptor liver and lymph node sinusoidal endotelial cell C-type lectin is expressed in human Kupffer cells and regulated by PU.1. Hepatology (2009) 0.81
Immunization with Leishmania infantum released proteins confers partial protection against parasite infection with a predominant Th1 specific immune response. Vaccine (2007) 0.81
Leishmania-induced inhibition of macrophage antigen presentation analyzed at the single-cell level. J Immunol (2003) 0.81
Multiphoton imaging of cytotoxic T lymphocyte-mediated antitumor immune responses. Curr Top Microbiol Immunol (2009) 0.80
The genome of the kinetoplastid parasite, Leishmania major. Science (2005) 8.64
Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur J Immunol (2003) 5.73
Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet (2007) 4.58
TriTrypDB: a functional genomic resource for the Trypanosomatidae. Nucleic Acids Res (2009) 3.79
The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat Immunol (2009) 3.27
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness. Nature (2010) 2.90
Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol (2002) 2.17
Myristoyl-CoA:protein N-myristoyltransferase, an essential enzyme and potential drug target in kinetoplastid parasites. J Biol Chem (2002) 2.08
Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania. Genome Res (2011) 1.90
RNA editing in Trypanosoma brucei requires three different editosomes. Mol Cell Biol (2007) 1.87
Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med (2002) 1.86
GeneDB--an annotation database for pathogens. Nucleic Acids Res (2011) 1.82
Molecules incorporating a benzothiazole core scaffold inhibit the N-myristoyltransferase of Plasmodium falciparum. Biochem J (2007) 1.75
Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses. Nat Med (2003) 1.75
Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect Immun (2004) 1.65
Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function. Immunity (2008) 1.65
The immunopathology of experimental visceral leishmaniasis. Immunol Rev (2004) 1.64
Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics. Mol Biochem Parasitol (2003) 1.61
Stromal cells direct local differentiation of regulatory dendritic cells. Immunity (2004) 1.58
Ether phospholipids and glycosylinositolphospholipids are not required for amastigote virulence or for inhibition of macrophage activation by Leishmania major. J Biol Chem (2003) 1.52
CD11b regulates recruitment of alveolar macrophages but not pulmonary dendritic cells after pneumococcal challenge. J Infect Dis (2005) 1.52
Determining disease intervention strategies using spatially resolved simulations. PLoS One (2013) 1.49
Sphingolipid-free Leishmania are defective in membrane trafficking, differentiation and infectivity. Mol Microbiol (2004) 1.45
Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat Immunol (2002) 1.44
Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells. Eur J Immunol (2006) 1.44
Variegated expression of CD8 alpha resulting from in situ deletion of regulatory sequences. Immunity (2002) 1.40
The protozoan inositol phosphorylceramide synthase: a novel drug target that defines a new class of sphingolipid synthase. J Biol Chem (2006) 1.39
Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs. PLoS Negl Trop Dis (2012) 1.36
Alveolar macrophages transport pathogens to lung draining lymph nodes. J Immunol (2009) 1.33
N-myristoyltransferase: a prospective drug target for protozoan parasites. ChemMedChem (2008) 1.33
Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis. Trends Parasitol (2004) 1.32
A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection. Am J Pathol (2002) 1.32
Dendritic cells at the host-pathogen interface. Nat Immunol (2002) 1.30
Contribution of neural crest-derived cells in the embryonic and adult thymus. J Immunol (2008) 1.30
Functional analysis of TbARL1, an N-myristoylated Golgi protein essential for viability in bloodstream trypanosomes. J Cell Sci (2005) 1.30
Characterization and selective inhibition of myristoyl-CoA:protein N-myristoyltransferase from Trypanosoma brucei and Leishmania major. Biochem J (2006) 1.30
N-myristoyltransferase from Leishmania donovani: structural and functional characterisation of a potential drug target for visceral leishmaniasis. J Mol Biol (2009) 1.28
Myristoyl-CoA:protein N-myristoyltransferase depletion in trypanosomes causes avirulence and endocytic defects. Mol Biochem Parasitol (2009) 1.28
Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity. Infect Immun (2003) 1.28
Trypanosoma brucei ARF1 plays a central role in endocytosis and golgi-lysosome trafficking. Mol Biol Cell (2006) 1.26
Site-specific N-terminal labelling of proteins in vitro and in vivo using N-myristoyl transferase and bioorthogonal ligation chemistry. Chem Commun (Camb) (2007) 1.25
IL-7-producing stromal cells are critical for lymph node remodeling. Blood (2012) 1.22
Kinetoplastid PPEF phosphatases: dual acylated proteins expressed in the endomembrane system of Leishmania. Mol Biochem Parasitol (2006) 1.21
Immunotherapy with OX40L-Fc or anti-CTLA-4 enhances local tissue responses and killing of Leishmania donovani. Eur J Immunol (2004) 1.19
Loss of dendritic cell migration and impaired resistance to Leishmania donovani infection in mice deficient in CCL19 and CCL21. J Immunol (2006) 1.19
Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection. Am J Pathol (2004) 1.17
Comparative expression profiling of Leishmania: modulation in gene expression between species and in different host genetic backgrounds. PLoS Negl Trop Dis (2009) 1.14
The stage-regulated HASPB and SHERP proteins are essential for differentiation of the protozoan parasite Leishmania major in its sand fly vector, Phlebotomus papatasi. Cell Microbiol (2010) 1.13
IL7-hCD25 and IL7-Cre BAC transgenic mouse lines: new tools for analysis of IL-7 expressing cells. Genesis (2009) 1.12
Localization of marginal zone macrophages is regulated by C-C chemokine ligands 21/19. J Immunol (2004) 1.09
The role played by tumor necrosis factor during localized and systemic infection with Streptococcus pneumoniae. J Infect Dis (2005) 1.09
Spartan: a comprehensive tool for understanding uncertainty in simulations of biological systems. PLoS Comput Biol (2013) 1.09
RepSeq--a database of amino acid repeats present in lower eukaryotic pathogens. BMC Bioinformatics (2007) 1.06
Stromal-cell regulation of dendritic-cell differentiation and function. Trends Immunol (2006) 1.01
Galectin-1-expressing stromal cells constitute a specific niche for pre-BII cell development in mouse bone marrow. Blood (2011) 1.00
IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c⁺ cell populations during visceral leishmaniasis. PLoS Pathog (2012) 1.00
CD8+ T-cell priming regulated by cytokines of the innate immune system. Trends Mol Med (2004) 0.99
Therapeutic vaccination with recombinant adenovirus reduces splenic parasite burden in experimental visceral leishmaniasis. J Infect Dis (2012) 0.98
Innate killing of Leishmania donovani by macrophages of the splenic marginal zone requires IRF-7. PLoS Pathog (2010) 0.98
Natural killer receptors: the burden of a name. J Exp Med (2010) 0.98
Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen. Infect Immun (2006) 0.98
Rafts and sphingolipid biosynthesis in the kinetoplastid parasitic protozoa. Mol Microbiol (2004) 0.97
Expression of vFLIP in a lentiviral vaccine vector activates NF-{kappa}B, matures dendritic cells, and increases CD8+ T-cell responses. J Virol (2008) 0.97
An evolutionarily conserved coiled-coil protein implicated in polycystic kidney disease is involved in basal body duplication and flagellar biogenesis in Trypanosoma brucei. Mol Cell Biol (2005) 0.97
Direct transport across the plasma membrane of mammalian cells of Leishmania HASPB as revealed by a CHO export mutant. J Cell Sci (2005) 0.97
Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitors. J Med Chem (2014) 0.95
Chemokine gene expression in toll-like receptor-competent and -deficient mice infected with Leishmania major. Infect Immun (2004) 0.95
The Schistosoma mansoni hepatic egg granuloma provides a favorable microenvironment for sustained growth of Leishmania donovani. Am J Pathol (2006) 0.95
Functional complexity of the Leishmania granuloma and the potential of in silico modeling. Front Immunol (2013) 0.95
Expression profiling of the Leishmania life cycle: cDNA arrays identify developmentally regulated genes present but not annotated in the genome. Mol Biochem Parasitol (2004) 0.94
IL-7: the global builder of the innate lymphoid network and beyond, one niche at a time. Semin Immunol (2012) 0.94
Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection. Infect Immun (2007) 0.94
VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis. PLoS Pathog (2008) 0.94
Leishmania-specific surface antigens show sub-genus sequence variation and immune recognition. PLoS Negl Trop Dis (2010) 0.93
Compartment-specific remodeling of splenic micro-architecture during experimental visceral leishmaniasis. Am J Pathol (2011) 0.92
Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice. J Clin Invest (2010) 0.92
The small GTPase ARL2 is required for cytokinesis in Trypanosoma brucei. Mol Biochem Parasitol (2010) 0.92